Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

aNational Institute for Health and Care Research Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK bFaculty of Medicine ...

WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...

Hims & Hers has been expanding its presence in the weight management market, with its existing Novo partnership representing ...

Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...

A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia / AP Share Excess body weight can raise the risk of certain cancers. So researchers ...

Over the past few years, demand for blockbuster medications like Ozempic, Wegovy and Zepbound skyrocketed ... the safety and efficacy of compounded medications are hard to verify.

Lisocabtagene maraleucel, an autologous CD19-directed CAR-T therapy, previously received approval in this patient population, though real-world data about the drug’s safety and efficacy are lacking.